logo
[breadcrumb_custom]

Tag: ADAP Stock
News

ADAP’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect?

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 46.28%. However, over the past six months, we’ve seen a weaker performance of 70.59%. The price of ADAP leaped by -27.04% over the last 30 days. And in the last five days, it has fallen by -15.33%. The stock market performance of Adaptimmune Therapeutics Plc ADR has been fairly unsteady. Over the last year, the company’s stock hit its highest at $2.05 on 03/08/24, while
Stock

Adaptimmune Therapeutics Plc ADR (ADAP) Stock: A Year of Declines and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Adaptimmune Therapeutics Plc ADR’s current trading price is -38.05% away from its 52-week high, while its distance from the 52-week low is 202.38%. The stock’s price range for this period has been between $0.42 and $2.05 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.48 million for the day, a number notably lower than the average daily volume of 1.89 million over the last three months. Adaptimmune Therapeutics Plc ADR’s market performance
Industry

ADAP’s Stock Market Puzzle: Piecing Together 2023’s Performance

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 81.59%. However, over the last six months, the performance has been weaker by 87.52%. The price of ADAP increased 4.35% over the last 30 days. And in the last five days, it has fallen by -2.70%. The market performance of Adaptimmune Therapeutics Plc ADR’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $2.05 on 03/08/24, while

SLGG
Stock

A Closer Look at Adaptimmune Therapeutics Plc ADR (ADAP) Stock Gains

Adaptimmune Therapeutics Plc ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $2.05 on 03/08/24 and the lowest value was $0.42 on 11/28/23. 52-week price history of ADAP Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Adaptimmune Therapeutics Plc ADR’s current trading price is -36.34% away from its 52-week high, while its distance from the 52-week low is 210.71%. The stock’s price range during the 52-week period has remained between $0.42 and $2.05. In the

HCCC Stock
Finance

Anchoring Your Portfolio: Is ADAP Stock a Safe Harbor?

Adaptimmune Therapeutics Plc ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $2.05 on 03/08/24 and the lowest value was $0.42 on 11/28/23. 52-week price history of ADAP Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Adaptimmune Therapeutics Plc ADR’s current trading price is -24.88% away from its 52-week high, while its distance from the 52-week low is 266.67%. The stock’s price range during this period has spanned from $0.42 to $2.05. In the Healthcare sector, the Adaptimmune Therapeutics Plc ADR’s
Industry

Adaptimmune Therapeutics Plc ADR (ADAP) Stock: The Story of a 52-Week Stock Range

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Adaptimmune Therapeutics Plc ADR’s current trading price is -4.47% away from its 52-week high, while its distance from the 52-week low is 307.14%. The stock’s price range during this period has varied between $0.42 and $1.79. The company, active in the Healthcare sector, saw a trading volume of around 2.21 million for the day, considerably higher average daily volume of 1.53 million observed over the last three months. Adaptimmune Therapeutics Plc ADR had a pretty

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
Facebook-f Twitter Google-plus-g Pinterest

Quick Links

Categories

©Fueled By Smart TechOne